Priority Date: 06.11.12 (US 201261723099P)

ALK KINASE INHIBITORS

  • Application ID: EP13853072
  • Status: GRANT OF PATENT INTENDED

Attorney

no operation time available
Headquarter in Bristol and 7 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 232 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 06.11.2012 - Priority Date (US 201261723099P)
  • 15.05.2014 - Publication A1 (WO2014071832)
  • 16.09.2015 - Publication A1 (EP2917210)

IPC Classification